Related Experiment Video
Updated: May 30, 2026
08:14
Comprehensive Analysis of Transcription Dynamics from Brain Samples Following Behavioral Experience
Published on: August 26, 2014
Notes from Underground: Are Cognitive-Enhancing Drugs Respecting their Promises?
1Cognitive Psychopathology Unit, University of Liège Liège, Belgium.
Frontiers in Psychology
|August 12, 2011
Summary
Pharmacological treatments for schizophrenia offer modest cognitive benefits, with limited evidence supporting atypical antipsychotics over typical ones. Real-world cognitive gains remain minimal despite statistical significance.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Psychology
Background:
- Cognitive deficits are a significant clinical feature of schizophrenia, impacting patient functioning.
- Developing effective pharmacological treatments for cognitive enhancement in schizophrenia is a major research focus.
- Current pharmacological interventions show limited, often modest, real-world benefits for cognitive functioning.
Purpose of the Study:
- To critically evaluate the efficacy of pharmacological agents in improving cognitive functioning in schizophrenia.
- To assess whether atypical antipsychotics offer superior cognitive benefits compared to typical agents.
- To examine the clinical and functional significance of observed cognitive gains and compare them to placebo effects.
Main Methods:
- Systematic review and meta-analysis of clinical trials investigating cognitive function in schizophrenia patients treated with pharmacological agents.
- Comparison of cognitive outcomes between typical and atypical antipsychotic medications.
- Analysis of treatment effect sizes in relation to clinical significance and placebo response.
Main Results:
- No convincing evidence indicates atypical antipsychotics are superior to typical agents for cognitive improvement in schizophrenia.
- Statistically significant cognitive gains are often small and imperceptible at the clinical and functional levels.
- Studies frequently fail to demonstrate a significant difference between drug treatment effects and placebo effects on cognition.
Conclusions:
- Current pharmacological interventions provide limited meaningful cognitive enhancement for schizophrenia patients.
- The modest efficacy highlights the need for alternative or adjunctive strategies for cognitive deficits in schizophrenia.
- Future research should focus on interventions with demonstrable clinical and functional impact on cognition.
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:22CNS Stimulants: Psychedelic Agents
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
01:28An Overview of Psychoactive Drugs
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:54The Placebo Effect
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.